Logo image of CGON

CG ONCOLOGY INC (CGON) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CGON - US1569441009 - Common Stock

54.45 USD
+1.87 (+3.56%)
Last: 1/14/2026, 11:44:03 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CGON revenue by date.CGON revenue by date.
191K
-98.16%
204K
6.81%
1.139M
458.33%
1.854M
62.77%
34.603M
1,766.40%
116.15M
235.66%
397.61M
242.32%
821.93M
106.72%
1.319B
60.48%
1.766B
33.89%
2.206B
24.92%
2.675B
21.26%
EBITDA
YoY % growth
CGON ebitda by date.CGON ebitda by date.
-35.231M
-179.70%
-55.432M
-57.34%
-114.634M
-106.80%
-200.9M
-75.25%
-242.514M
-20.71%
-254.22M
-4.83%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CGON ebit by date.CGON ebit by date.
-35.246M
-179.60%
-55.449M
-57.32%
-114.666M
-106.80%
-200.539M
-74.89%
-241.287M
-20.32%
-234.391M
2.86%
-32.758M
86.02%
287.48M
977.60%
671.44M
133.56%
1.103B
64.27%
1.436B
30.19%
1.534B
6.82%
Operating Margin
CGON operating margin by date.CGON operating margin by date.
-18,453.40%-27,180.88%-10,067.25%-10,816.56%-697.30%-201.80%-8.24%34.98%50.91%62.46%65.10%57.35%
EPS
YoY % growth
CGON eps by date.CGON eps by date.
N/AN/A-1.42
-4.48%
-2.22
-56.59%
-2.67
-20.24%
-2.41
9.77%
-0.28
88.48%
2.81
1,110.64%
6.20
120.70%
9.83
58.60%
12.56
27.72%
11.44
-8.87%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.63
-30.72%
-0.68
-51.36%
-0.71
-32.35%
-0.75
-31.86%
-0.80
-27.83%
Revenue
Q2Q % growth
484.5K
6.25%

-100.00%
291.424K
-82.51%
4.473M
823.22%
EBITDA
Q2Q % growth
-54.777M
-44.09%
-55.452M
-31.47%
-62.89M
-29.51%
N/AN/A
EBIT
Q2Q % growth
-55.864M
-46.82%
-58.362M
-38.28%
-61.726M
-26.64%
-66.157M
-29.39%
-65.749M
-17.70%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.57
-90.00%
-0.570.000.21%
Q2 2025
Q2Q % growth
-0.54
-92.86%
-0.47-0.07-15.32%
Q1 2025
Q2Q % growth
-0.45
-25.00%
-0.41-0.04-9.38%
Q4 2024
Q2Q % growth
-0.48
89.02%
-0.36-0.12-33.19%
Q3 2024
Q2Q % growth
-0.30 -0.370.0719.89%
Q2 2024
Q2Q % growth
-0.28 -0.380.1026.21%
Q1 2024
Q2Q % growth
-0.36 -0.30-0.06-21.70%
Q4 2023
Q2Q % growth
-4.37 -0.69-3.68-534.71%
CGON Yearly EPS VS EstimatesCGON Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.666M
3,774.42%
66.606K1.599M2,401.28%
Q2 2025
Q2Q % growth

-100.00%
126.103K-126.103K-100.00%
Q1 2025
Q2Q % growth
52K
-90.17%
217.005K-165.005K-76.04%
Q4 2024
Q2Q % growth
456K
45,500.00%
76.5K379.5K496.08%
Q3 2024
Q2Q % growth
43K
-78.82%
106.284K-63.284K-59.54%
Q2 2024
Q2Q % growth
111K 179.857K-68.857K-38.28%
Q3 2023
Q2Q % growth
203K
6.28%
%
CGON Yearly Revenue VS EstimatesCGON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.68% -4.42% -0.88% -1.3%
Revenue-16.23% -24.38% -2.01% 623.76%